INS and Hyperglycemia: Accordingly, robust hyperglycemia-induced endothelial dysfunction and altered insulin signaling-induced PVAT dysfunction seem both responsible for severe vascular dysfunction occurring just after 2 weeks of administration of S961 in mice.